Structural determinants of host defense peptides for antimicrobial activity and target cell selectivity

Biochimie

Volumn 92, Issue 9, 2010, Pages 1236-1241

  Takahashi, Daisuke ^a   Shukla, Sanjeev K ^a   Prakash, Om ^a   Zhang, Guolong ^b  

^a KANSAS STATE UNIVERSITY   (United States)

^b OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Antimicrobial peptides; Antimicrobial resistance; Host defense peptides; Structure activity relationship

Indexed keywords

ANTIMICROBIAL ACTIVITY; HOST RESISTANCE; HYDROPHOBICITY; IMMUNITY; NONHUMAN; PHYSICAL CHEMISTRY; REVIEW;

ANTI-INFECTIVE AGENTS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; IMMUNITY, INNATE; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; STRUCTURE-ACTIVITY RELATIONSHIP;

EUKARYOTA;

EID: 77955846576     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2010.02.023     Document Type: Review

References (79)

1. Spellberg B., Powers J.H., Brass E.P., Miller L.G., Edwards J.E. Trends in antimicrobial drug development: implications for the future. Clin. Infect. Dis. 2004, 38:1279-1286.
2. Hancock R.E., Sahl H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 2006, 24:1551-1557.
3. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415:389-395.
4. Zanetti M., Gennaro R., Skerlavaj B., Tomasinsig L., Circo R. Cathelicidin peptides as candidates for a novel class of antimicrobials. Curr. Pharm. Des. 2002, 8:779-793.
5. Peschel A., Sahl H.G. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 2006, 4:529-536.
6. Mookherjee N., Rehaume L.M., Hancock R.E. Cathelicidins and functional analogues as antisepsis molecules. Expert Opin. Ther. Targets 2007, 11:993-1004.
7. Lai Y., Gallo R.L. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009, 30:131-141.
8. Oppenheim J.J., Yang D. Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 2005, 17:359-365.
9. Easton D.M., Nijnik A., Mayer M.L., Hancock R.E. Potential of immunomodulatory host defense peptides as novel anti-infectives. Trends Biotechnol. 2009, 27:582-590.
10. Tossi A., Sandri L. Molecular diversity in gene-encoded, cationic antimicrobial polypeptides. Curr. Pharm. Des. 2002, 8:743-761.
11. Tossi A., Sandri L., Giangaspero A. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 2000, 55:4-30.
12. Wang G. Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J. Biol. Chem. 2008, 283:32637-32643.
13. Hultmark D., Steiner H., Rasmuson T., Boman H.G. Insect immunity. Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia. Eur. J. Biochem. 1980, 106:7-16.
14. Terwilliger T.C., Eisenberg D. The structure of melittin. I. Structure determination and partial refinement. J. Biol. Chem. 1982, 257:6010-6015.
15. Terwilliger T.C., Eisenberg D. The structure of melittin. II. Interpretation of the structure. J. Biol. Chem. 1982, 257:6016-6022.
16. 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an alpha-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution. J. Biomol. NMR 1997, 9:127-135.
17. Xiao Y., Dai H., Bommineni Y.R., Soulages J.L., Gong Y.X., Prakash O., Zhang G. Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken. FEBS J. 2006, 273:2581-2593.
18. Xiao Y., Herrera A.I., Bommineni Y.R., Soulages J.L., Prakash O., Zhang G. The Central kink region of fowlicidin-2, an alpha-helical host defense peptide, is critically involved in bacterial killing and endotoxin neutralization. J. Innate Immun. 2009, 1:268-280.
19. Bommineni Y.R., Dai H., Gong Y.X., Soulages J.L., Fernando S.C., Desilva U., Prakash O., Zhang G. Fowlicidin-3 is an alpha-helical cationic host defense peptide with potent antibacterial and lipopolysaccharide-neutralizing activities. FEBS J. 2007, 274:418-428.
20. Mani R., Tang M., Wu X., Buffy J.J., Waring A.J., Sherman M.A., Hong M. Membrane-bound dimer structure of a beta-hairpin antimicrobial peptide from rotational-echo double-resonance solid-state NMR. Biochemistry 2006, 45:8341-8349.
21. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 2003, 3:710-720.
22. Lehrer R.I. Primate defensins. Nat. Rev. Microbiol. 2004, 2:727-738.
23. Selsted M.E., Ouellette A.J. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 2005, 6:551-557.
24. Xiao Y., Hughes A.L., Ando J., Matsuda Y., Cheng J.F., Skinner-Noble D., Zhang G. A genome-wide screen identifies a single beta-defensin gene cluster in the chicken: implications for the origin and evolution of mammalian defensins. BMC Genomics 2004, 5:56.
25. Patil A., Hughes A.L., Zhang G. Rapid evolution and diversification of mammalian alpha-defensins as revealed by comparative analysis of rodent and primate genes. Physiol. Genomics 2004, 20:1-11.
26. Patil A.A., Cai Y., Sang Y., Blecha F., Zhang G. Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract. Physiol. Genomics 2005, 23:5-17.
27. Szyk A., Wu Z., Tucker K., Yang D., Lu W., Lubkowski J. Crystal structures of human alpha-defensins HNP4, HD5, and HD6. Protein Sci. 2006, 15:2749-2760.
28. Wu Z., Li X., de Leeuw E., Ericksen B., Lu W. Why is the Arg5-Glu13 salt bridge conserved in mammalian alpha-defensins?. J. Biol. Chem. 2005, 280:43039-43047.
29. Xie C., Prahl A., Ericksen B., Wu Z., Zeng P., Li X., Lu W.Y., Lubkowski J., Lu W. Reconstruction of the conserved beta-bulge in mammalian defensins using d-amino acids. J. Biol. Chem. 2005, 280:32921-32929.
30. Rozek A., Friedrich C.L., Hancock R.E. Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles. Biochemistry 2000, 39:15765-15774.
31. Schibli D.J., Hwang P.M., Vogel H.J. Structure of the antimicrobial peptide tritrpticin bound to micelles: a distinct membrane-bound peptide fold. Biochemistry 1999, 38:16749-16755.
32. Oppenheim F.G., Xu T., McMillian F.M., Levitz S.M., Diamond R.D., Offner G.D., Troxler R.F. Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J. Biol. Chem. 1988, 263:7472-7477.
33. Agerberth B., Lee J.Y., Bergman T., Carlquist M., Boman H.G., Mutt V., Jornvall H. Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur. J. Biochem. 1991, 202:849-854.
34. Shi J., Ross C.R., Chengappa M.M., Blecha F. Identification of a proline-arginine-rich antibacterial peptide from neutrophils that is analogous to PR-39, an antibacterial peptide from the small intestine. J. Leukoc. Biol. 1994, 56:807-811.
35. Yang D., Chertov O., Bykovskaia S.N., Chen Q., Buffo M.J., Shogan J., Anderson M., Schroder J.M., Wang J.M., Howard O.M., Oppenheim J.J. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999, 286:525-528.
36. De Y., Chen Q., Schmidt A.P., Anderson G.M., Wang J.M., Wooters J., Oppenheim J.J., Chertov O. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 2000, 192:1069-1074.
37. Biragyn A., Ruffini P.A., Leifer C.A., Klyushnenkova E., Shakhov A., Chertov O., Shirakawa A.K., Farber J.M., Segal D.M., Oppenheim J.J., Kwak L.W. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 2002, 298:1025-1029.
38. Elssner A., Duncan M., Gavrilin M., Wewers M.D. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J. Immunol. 2004, 172:4987-4994.
39. Tjabringa G.S., Aarbiou J., Ninaber D.K., Drijfhout J.W., Sorensen O.E., Borregaard N., Rabe K.F., Hiemstra P.S. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J. Immunol. 2003, 171:6690-6696.
40. Leikina E., Delanoe-Ayari H., Melikov K., Cho M.S., Chen A., Waring A.J., Wang W., Xie Y., Loo J.A., Lehrer R.I., Chernomordik L.V. Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nat. Immunol. 2005, 6:995-1001.
41. Gallo S.A., Wang W., Rawat S.S., Jung G., Waring A.J., Cole A.M., Lu H., Yan X., Daly N.L., Craik D.J., Jiang S., Lehrer R.I., Blumenthal R. Theta-defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation. J. Biol. Chem. 2006, 281:18787-18792.
42. Mookherjee N., Lippert D.N., Hamill P., Falsafi R., Nijnik A., Kindrachuk J., Pistolic J., Gardy J., Miri P., Naseer M., Foster L.J., Hancock R.E. Intracellular receptor for human host defense peptide LL-37 in monocytes. J. Immunol. 2009, 183:2688-2696.
43. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat. Rev. Microbiol. 2005, 3:238-250.
44. Chan D.I., Prenner E.J., Vogel H.J. Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochim. Biophys. Acta 2006, 1758:1184-1202.
45. Chen Y., Vasil A.I., Rehaume L., Mant C.T., Burns J.L., Vasil M.L., Hancock R.E., Hodges R.S. Comparison of biophysical and biologic properties of alpha-helical enantiomeric antimicrobial peptides. Chem. Biol. Drug Des. 2006, 67:162-173.
46. Wei G., de Leeuw E., Pazgier M., Yuan W., Zou G., Wang J., Ericksen B., Lu W.Y., Lehrer R.I., Lu W. Through the looking glass, mechanistic insights from enantiomeric human defensins. J. Biol. Chem. 2009, 284:29180-29192.
47. Miteva M., Andersson M., Karshikoff A., Otting G. Molecular electroporation: a unifying concept for the description of membrane pore formation by antibacterial peptides, exemplified with NK-lysin. FEBS Lett. 1999, 462:155-158.
48. Pokorny A., Almeida P.F. Kinetics of dye efflux and lipid flip-flop induced by delta-lysin in phosphatidylcholine vesicles and the mechanism of graded release by amphipathic, alpha-helical peptides. Biochemistry 2004, 43:8846-8857.
49. Dathe M., Wieprecht T. Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochim. Biophys. Acta 1999, 1462:71-87.
50. Yeaman M.R., Yount N.Y. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 2003, 55:27-55.
51. Chen Y., Mant C.T., Farmer S.W., Hancock R.E., Vasil M.L., Hodges R.S. Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J. Biol. Chem. 2005, 280:12316-12329.
52. Dathe M., Nikolenko H., Meyer J., Beyermann M., Bienert M. Optimization of the antimicrobial activity of magainin peptides by modification of charge. FEBS Lett. 2001, 501:146-150.
53. Schibli D.J., Hunter H.N., Aseyev V., Starner T.D., Wiencek J.M., McCray P.B., Tack B.F., Vogel H.J. The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J. Biol. Chem. 2002, 277:8279-8289.
54. Wieprecht T., Dathe M., Krause E., Beyermann M., Maloy W.L., MacDonald D.L., Bienert M. Modulation of membrane activity of amphipathic, antibacterial peptides by slight modifications of the hydrophobic moment. FEBS Lett. 1997, 417:135-140.
55. Kondejewski L.H., Jelokhani-Niaraki M., Farmer S.W., Lix B., Kay C.M., Sykes B.D., Hancock R.E., Hodges R.S. Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. J. Biol. Chem. 1999, 274:13181-13192.
56. Wieprecht T., Dathe M., Beyermann M., Krause E., Maloy W.L., MacDonald D.L., Bienert M. Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. Biochemistry 1997, 36:6124-6132.
57. Chen Y., Guarnieri M.T., Vasil A.I., Vasil M.L., Mant C.T., Hodges R.S. Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Antimicrob. Agents Chemother. 2007, 51:1398-1406.
58. Houston M.E., Kondejewski L.H., Karunaratne D.N., Gough M., Fidai S., Hodges R.S., Hancock R.E. Influence of preformed alpha-helix and alpha-helix induction on the activity of cationic antimicrobial peptides. J. Pept. Res. 1998, 52:81-88.
59. Taylor K., Barran P.E., Dorin J.R. Structure-activity relationships in beta-defensin peptides. Biopolymers 2008, 90:1-7.
60. Mandal M., Jagannadham M.V., Nagaraj R. Antibacterial activities and conformations of bovine beta-defensin BNBD-12 and analogs: structural and disulfide bridge requirements for activity. Peptides 2002, 23:413-418.
61. Hoover D.M., Wu Z., Tucker K., Lu W., Lubkowski J. Antimicrobial characterization of human beta-defensin 3 derivatives. Antimicrob. Agents Chemother. 2003, 47:2804-2809.
62. Kluver E., Schulz-Maronde S., Scheid S., Meyer B., Forssmann W.G., Adermann K. Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity. Biochemistry 2005, 44:9804-9816.
63. Wu Z., Hoover D.M., Yang D., Boulegue C., Santamaria F., Oppenheim J.J., Lubkowski J., Lu W. Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:8880-8885.
64. Yau W.M., Wimley W.C., Gawrisch K., White S.H. The preference of tryptophan for membrane interfaces. Biochemistry 1998, 37:14713-14718.
65. Dougherty D.A. Cation-pi interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp. Science 1996, 271:163-168.
66. Subbalakshmi C., Bikshapathy E., Sitaram N., Nagaraj R. Antibacterial and hemolytic activities of single tryptophan analogs of indolicidin. Biochem. Biophys. Res. Commun. 2000, 274:714-716.
67. Deslouches B., Phadke S.M., Lazarevic V., Cascio M., Islam K., Montelaro R.C., Mietzner T.A. De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity. Antimicrob. Agents Chemother. 2005, 49:316-322.
68. Staubitz P., Peschel A., Nieuwenhuizen W.F., Otto M., Gotz F., Jung G., Jack R.W. Structure-function relationships in the tryptophan-rich, antimicrobial peptide indolicidin. J. Pept. Sci. 2001, 7:552-564.
69. Vogel H.J., Schibli D.J., Jing W., Lohmeier-Vogel E.M., Epand R.F., Epand R.M. Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides. Biochem. Cell Biol. 2002, 80:49-63.
70. Pasupuleti M., Schmidtchen A., Chalupka A., Ringstad L., Malmsten M. End-tagging of ultra-short antimicrobial peptides by W/F stretches to facilitate bacterial killing. PLoS One 2009, 4:e5285.
71. Schmidtchen A., Pasupuleti M., Morgelin M., Davoudi M., Alenfall J., Chalupka A., Malmsten M. Boosting antimicrobial peptides by hydrophobic oligopeptide end tags. J. Biol. Chem. 2009, 284:17584-17594.
72. Mandard N., Sodano P., Labbe H., Bonmatin J.M., Bulet P., Hetru C., Ptak M., Vovelle F. Solution structure of thanatin, a potent bactericidal and fungicidal insect peptide, determined from proton two-dimensional nuclear magnetic resonance data. Eur. J. Biochem. 1998, 256:404-410.
73. Laederach A., Andreotti A.H., Fulton D.B. Solution and micelle-bound structures of tachyplesin I and its active aromatic linear derivatives. Biochemistry 2002, 41:12359-12368.
74. Fahrner R.L., Dieckmann T., Harwig S.S., Lehrer R.I., Eisenberg D., Feigon J. Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes. Chem. Biol. 1996, 3:543-550.
75. Lin K.F., Lee T.R., Tsai P.H., Hsu M.P., Chen C.S., Lyu P.C. Structure-based protein engineering for alpha-amylase inhibitory activity of plant defensin. Proteins 2007, 68:530-540.
76. Mygind P.H., Fischer R.L., Schnorr K.M., Hansen M.T., Sonksen C.P., Ludvigsen S., Raventos D., Buskov S., Christensen B., De Maria L., Taboureau O., Yaver D., Elvig-Jorgensen S.G., Sorensen M.V., Christensen B.E., Kjaerulff S., Frimodt-Moller N., Lehrer R.I., Zasloff M., Kristensen H.H. Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 2005, 437:975-980.
77. Cornet B., Bonmatin J.M., Hetru C., Hoffmann J.A., Ptak M., Vovelle F. Refined three-dimensional solution structure of insect defensin A. Structure 1995, 3:435-448.
78. Hill C.P., Yee J., Selsted M.E., Eisenberg D. Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science 1991, 251:1481-1485.
79. Daly N.L., Chen Y.K., Rosengren K.J., Marx U.C., Phillips M.L., Waring A.J., Wang W., Lehrer R.I., Craik D.J. Retrocyclin-2: structural analysis of a potent anti-HIV theta-defensin. Biochemistry 2007, 46:9920-9928.